Ultragenyx Pharmaceutical Inc.
2014 Q2 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/30/2026 | 681 | 0.0% | 29,604 | 12/31/2025 |
| 2025 Q3 | 11/7/2025 | 2,167 | 0.0% | 72,055 | 9/30/2025 |
| 2025 Q2 | 7/31/2025 | 1,929 | 0.0% | 53,040 | 6/30/2025 |
| 2024 Q4 | 1/31/2025 | 1,957 | 0.0% | 46,514 | 12/31/2024 |
| 2024 Q3 | 11/4/2024 | 1,931 | 0.0% | 34,769 | 9/30/2024 |
| 2024 Q2 | 8/7/2024 | 2,004 | 0.0% | 48,764 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 2,591 | 0.0% | 55,485 | 3/31/2024 |
| 2023 Q4 | 2/2/2024 | 3,112 | 0.0% | 65,068 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 2,436 | 0.0% | 68,337 | 9/30/2023 |
| 2023 Q2 | 8/2/2023 | 2,320 | 0.0% | 50,292 | 6/30/2023 |
| 2023 Q1 | 4/26/2023 | 2,017 | 0.0% | 50,292 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 3,120 | 0.0% | 67,341 | 12/31/2022 |
| 2022 Q3 | 10/28/2022 | 1,958 | 0.0% | 47,289 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 2,821 | 0.0% | 47,289 | 6/30/2022 |
| 2022 Q1 | 5/3/2022 | 3,220 | 0.0% | 44,338 | 3/31/2022 |
| 2021 Q4 | 1/31/2022 | 3,556 | 0.0% | 42,284 | 12/31/2021 |
| 2021 Q3 | 10/27/2021 | 3,800 | 0.0% | 42,132 | 9/30/2021 |
| 2021 Q2 | 7/23/2021 | 3,773 | 0.0% | 39,570 | 6/30/2021 |
| 2021 Q1 | 4/27/2021 | 4,368 | 0.0% | 38,360 | 3/31/2021 |
| 2020 Q4 | 2/3/2021 | 5,268 | 0.0% | 38,055 | 12/31/2020 |
| 2020 Q3 | 10/27/2020 | 3,337 | 0.0% | 40,604 | 9/30/2020 |
| 2020 Q2 | 8/4/2020 | 3,215 | 0.0% | 41,096 | 6/30/2020 |
| 2020 Q1 | 6/19/2020 | 2,619 | 0.0% | 58,944 | 3/31/2020 |
| 2019 Q4 | 1/31/2020 | 2,517 | 0.0% | 58,944 | 12/31/2019 |
| 2014 Q2 | 8/11/2014 | 422 | 0.0% | 9,400 | 6/30/2014 |